Cymat Technologies Ltd.
CYMHF
$0.0875
-$0.014-13.79%
| Weiss Ratings | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.87 | |||
| Price History | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -13.79% | |||
| 30-Day Total Return | -9.70% | |||
| 60-Day Total Return | 2.94% | |||
| 90-Day Total Return | 0.69% | |||
| Year to Date Total Return | 2.94% | |||
| 1-Year Total Return | -37.37% | |||
| 2-Year Total Return | -74.14% | |||
| 3-Year Total Return | -81.10% | |||
| 5-Year Total Return | -57.59% | |||
| 52-Week High % Change | -38.47% | |||
| 52-Week Low % Change | 42.97% | |||
| Price | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.14 | |||
| 52-Week Low Price | $0.06 | |||
| 52-Week Low Price (Date) | Sep 25, 2024 | |||
| 52-Week High Price (Date) | May 15, 2024 | |||
| Valuation | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.43M | |||
| Enterprise Value | 8.51M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.04 | |||
| Earnings Per Share Growth | -41.25% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.81 | |||
| Price/Book (Q) | -1.87 | |||
| Enterprise Value/Revenue (TTM) | 4.19 | |||
| Price | $0.09 | |||
| Enterprise Value/EBITDA (TTM) | -5.12 | |||
| Enterprise Value/EBIT | -4.38 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 65.69M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 905-696-9900 | |||
| Address | 6320-2 Danville Road Mississauga, ON L5T 2L7 | |||
| Website | www.cymat.com | |||
| Country | Canada | |||
| Year Founded | 2006 | |||
| Profitability | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -95.78% | |||
| Profit Margin | -120.71% | |||
| Management Effectiveness | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -49.32% | |||
| Return on Equity | -- | |||
| Income Statement | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 2.05M | |||
| Total Revenue (TTM) | 2.05M | |||
| Revenue Per Share | $0.03 | |||
| Gross Profit (TTM) | 300.80K | |||
| EBITDA (TTM) | -1.68M | |||
| EBIT (TTM) | -1.96M | |||
| Net Income (TTM) | -2.47M | |||
| Net Income Avl. to Common (TTM) | -2.47M | |||
| Total Revenue Growth (Q YOY) | 193.86% | |||
| Earnings Growth (Q YOY) | 24.30% | |||
| EPS Diluted (TTM) | -0.04 | |||
| EPS Diluted Growth (Q YOY) | 29.33% | |||
| Balance Sheet | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 151.70K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 932.70K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -3.07M | |||
| Current Ratio (Q) | 0.226 | |||
| Book Value Per Share (Q) | -$0.05 | |||
| Total Assets (Q) | 2.50M | |||
| Total Current Liabilities (Q) | 4.12M | |||
| Total Debt (Q) | 3.35M | |||
| Total Liabilities (Q) | 5.58M | |||
| Total Common Equity (Q) | -3.07M | |||
| Cash Flow | CYMHF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -35.50K | |||
| Cash from Financing (TTM) | 1.11M | |||
| Net Change in Cash (TTM) | 400.00 | |||
| Levered Free Cash Flow (TTM) | -786.80K | |||
| Cash from Operations (TTM) | -1.08M | |||
